Free Trial
→ Ticker Revealed: Pre-IPO Access to 'Next Elon Musk' Company (From Banyan Hill Publishing) (Ad)tc pixel
NASDAQ:ARAY

Accuray Q1 2027 Earnings Date & Estimates

Accuray logo
$0.17 0.00 (-0.74%)
Closing price 04:00 PM Eastern
Extended Trading
$0.18 +0.01 (+3.57%)
As of 07:44 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Accuray is estimated to report Q1 2027 earnings on Wednesday, November 4, 2026, after market closes. The conference call is scheduled for 4:30 PM ET.

Research:ProfileEarnings HistoryForecast

Upcoming Earnings Announcement

Quarter
Q1 2027
Announcement Date
Time
After Market Closes
Conference Call
4:30 PM ET
Google Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab)

What Analysts Expect from Accuray in Q1 2027

Accuray is expected to post earnings of -$0.07 per share on revenue of $95.80 million. In the same quarter a year earlier Accuray reported -$0.18 per share on revenue of $93.94 million. Accuray last reported on August 19, 2026, posting -$0.02 per share and beating the -$0.03 consensus estimate. Accuray has beaten the consensus EPS estimate in 3 of its last 8 quarters.

Consensus Estimates

Consensus EPS
-$0.07
Expected Revenue
$95.80 million
Prior-Year EPS
-$0.18
Prior-Year Revenue
$93.94 million
Expected Revenue Growth
+2.0%

Recent Track Record

Last Reported
Q4 2026
Last Quarter EPS
-$0.02 (Beat by +$0.01)
Last Quarter Revenue
$100.92 million
EPS Beat Rate
3 of last 8 quarters

Prepare for the Q1 2027 Call

Accuray Q1 2027 Earnings FAQ

Accuray (NASDAQ:ARAY) is estimated to report Q1 2027 earnings on Wednesday, November 4, 2026, after market closes. This date is estimated from past reporting schedules and may change once the company confirms it.

Accuray's Q1 2027 earnings conference call is scheduled for Wednesday, November 4, 2026 at 4:30 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Analysts expect Accuray to post earnings of -$0.07 per share for Q1 2027.

The consensus revenue estimate for Accuray is $95.80 million for Q1 2027.

Accuray Earnings Headlines

Accuray announces upcoming board change and governance continuity
October 13 at 4:50 PM  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/accuray-announces-upcoming-board-change-and-governance-continuity?utm_source=marketbeat.com&utm_medium=referral
Accuray Stockholders Approve Financing, Share Increase and Reverse Split Authority
October 8, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31098186
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially the reasons why we’re bombing the country.tc pixel
October 15 at 1:00 AM  |  Banyan Hill Publishing (Ad)
Head-To-Head Survey: RxSight (NASDAQ:RXST) versus Accuray (NASDAQ:ARAY)
October 7, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31095349
Accuray Shareholders Approve Financing and Reverse Stock Split
October 6, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/accuray-shareholders-approve-financing-and-reverse-stock-split?utm_source=marketbeat.com&utm_medium=referral
Accuray Announces Stockholder Approval of Key Financing-Related Proposals and Appointment of New Independent Director
October 6, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/accuray-announces-stockholder-approval-of-key-financing-related-proposals-and-appointment-of-new-independent-director-302900306.html
See More Accuray Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Accuray? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Accuray and other key companies, straight to your email.

About Accuray

Accuray (NASDAQ:ARAY) (NASDAQ: ARAY) is a medical technology company that develops, manufactures and supports radiation therapy systems used primarily in the treatment of cancer. Its technologies are designed to deliver highly targeted radiation while helping clinicians manage tumor motion and limit exposure to surrounding healthy tissue.

The company’s product portfolio includes the CyberKnife System, a robotic stereotactic radiosurgery and radiotherapy platform, and the Radixact System, an image-guided radiation therapy platform based on helical delivery technology. Accuray also provides treatment-planning software, clinical applications, installation, training, maintenance and other support services for healthcare providers.

Accuray was founded in 1990 and is headquartered in Madison, Wisconsin. The company sells and supports its systems through direct operations and commercial partners in markets around the world, serving hospitals, cancer centers and other radiation oncology facilities. Accuray acquired TomoTherapy in 2011, expanding its portfolio to include the technology that became the foundation for its Radixact systems.

View Accuray Profile
Earnings Tools